| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia; and the 2 Medical Research Council Human Genetics Unit, Western General Hospital, Edinburgh, Scotland, United Kingdom.
PURPOSE. To define early disease expression in autosomal dominant late-onset retinal degeneration (L-ORD), a retinopathy that becomes symptomatic after age 50 and is characterized histopathologically by sub-RPE deposits.
METHODS. Three families with L-ORD were included; two families had postmortem eye donors with retina-wide sub-RPE deposits. Six patients with severe visual loss (ages 62–93) were examined clinically, and 17 available individuals (ages 35–60) at a 50:50 risk to inherit L-ORD were also studied with dark adaptometry. A short-term trial of vitamin A at 50,000 IU/day was conducted in three members. Three-year follow-up examinations were performed in a subset of members.
RESULTS. Family 1 had 12 available members at risk. On initial examination, only one member had fundus abnormalities: yellow-white punctate lesions in the midperipheral fundus. Dark-adaptation kinetics were abnormal in 6 of 12. The youngest age with an abnormality was 35. Family 2 had two available members at risk, both of whom had punctate fundus lesions and abnormal dark adaptation. Family 3 had three available members at risk. One had fundus lesions and abnormal dark adaptation, whereas the others had normal fundi and normal adaptometry. Vitamin A accelerated adaptation kinetics but not to normal rates. Three-year follow-up examinations demonstrated further slowing of adaptation kinetics, whereas rod and cone thresholds remained unchanged.
CONCLUSIONS. Dark-adaptation abnormalities can precede symptoms and funduscopic signs of L-ORD by at least a decade. Short-term, high-dose vitamin A accelerates the kinetics of dark adaptation to a limited degree. The results contribute clues about early pathophysiology of this retinal degeneration and provide additional power for genetic mapping of the L-ORD locus.
This article has been cited by other articles:
|
|
 |
|
  X. Shu, B. Tulloch, A. Lennon, D. Vlachantoni, X. Zhou, C. Hayward, and A. F. Wright Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5 Hum. Mol. Genet., May 15, 2006; 15(10): 1680 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Owsley, G. McGwin, G. R. Jackson, D. C. Heimburger, C. J. Piyathilake, R. Klein, M. F. White, and K. Kallies Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1310 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ayyagari, M. N. A. Mandal, A. J. Karoukis, L. Chen, N. C. McLaren, M. Lichter, D. T. Wong, P. F. Hitchcock, R. C. Caruso, S. E. Moroi, et al. Late-Onset Macular Degeneration and Long Anterior Lens Zonules Result from a CTRP5 Gene Mutation Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3363 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Cideciyan, T. S. Aleman, M. Swider, S. B. Schwartz, J. D. Steinberg, A. J. Brucker, A. M. Maguire, J. Bennett, E. M. Stone, and S. G. Jacobson Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence Hum. Mol. Genet., March 1, 2004; 13(5): 525 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hayward, X. Shu, A. V. Cideciyan, A. Lennon, P. Barran, S. Zareparsi, L. Sawyer, G. Hendry, B. Dhillon, A. H. Milam, et al. Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration Hum. Mol. Genet., October 16, 2003; 12(20): 2657 - 2667. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
